Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @bpdealmakers
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @bpdealmakers
-
Prikvačeni tweet
Introducing our first December issue....as usual we include a variety of
#pharma and#biotech companies looking to partner. Our editorials cover deals targeting the#inflammation complement cascade and a review of the year's high value partnering deals. https://go.nature.com/34TjbSoHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're preparing our content for our first issue of 2020. In the meantime, check out
#Glycostem who have developed an affordable off-the-shelf cell therapy product indicated for#oncology#therapieshttps://go.nature.com/30vFrAhHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioPharma Dealmakers proslijedio/la je Tweet
2019 FDA drug approvals https://go.nature.com/2QyodPk The FDA approved 48 new drugs last year, keeping up the momentum of recent years - find out more about them in our annual analysis by
@AsherMullardpic.twitter.com/N3Qnm13J6K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 saw a boom in high-value M&A and licensing deals, with oncology and rare diseases as prominent themes. Look back on such deals in our round up article from our December Issue
#deals#oncology#rarediseases#biopharmadealshttps://go.nature.com/2SPS6MSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Biopharmas targeting common viral denominators to battle flu"
#infectiousdiseases#influenza#vaccineshttps://go.nature.com/2QG0E7JHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy 25th Birthday to
#BIOEurope! Another productive and well organised conference. Don't forget to pick your copy up of our#November edition for the journey home or read online.#influenza https://go.nature.com/2qR2OXe pic.twitter.com/cc2Kia1qRX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioPharma Dealmakers proslijedio/la je Tweet
This week on the Nature cover: 150 years of Nature. A web of multidisciplinary research and discovery. Browse the issue here: https://go.nature.com/33A8OSE
#Nature150pic.twitter.com/XqfCb3oeiKHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The November issue is now available, featuring companies targeting
#infectiousdiseases including#Influenza Our editorials also focus on the#flu virus and the art of closing a#biopharma deal Read the full issue herehttps://go.nature.com/33h56gUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioPharma Dealmakers proslijedio/la je Tweet
Read the first article published in Nature written by T. H. Huxley that was issued on this date in 1869.
#Nature150https://go.nature.com/32fpsFGHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The search for checkpoint inhibitor partners: Immuno-oncology continues to be a highly active area for dealmaking as leading companies seek to expand the treatable patient population for checkpoint inhibitors
#oncology#partnering#biopharmahttps://go.nature.com/2MIFcwFHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Wafermine: the world’s first patented sublingual racemic ketamine wafer for pain and depression."
#iXBiopharma is transferring approved drugs into novel therapies to develop therapies for pain, depression and other conditions#pain#depression#biopharmahttps://go.nature.com/2pHdfMyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biopharma dealmaking: negotiating your term sheet. Lubor Gaal, senior VP, Head of Europe of
@LocustWalkPtrs discusses how licensors can negotiate the best terms for their biopharma assets in our September issue#dealmaking#biopharmahttps://go.nature.com/2VTKYOPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Which companies were involved with the biggest
#biopharma deals of summer 2019? One deal involved@Amgen and another@GileadSciences Read about the deals that made headlines in July and August https://go.nature.com/2p6z4F4 in our deals collection.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Developers of AlivaMab Mouse and AlivaMab Discovery Services,
#Ablexis offer customized and streamlined solutions for companies and organisations looking to obtain efficacious and derisked therapeutic#antibodies#drugdiscoveryhttps://go.nature.com/2p7X7DqHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Delivering digital cell biology at light speed" Read about
@berkeley_lights, pioneer and leader in the emerging field of digital cell biology, delivering breakthrough technology and platforms that fundamentally change research#oncology#cellbiologyhttps://go.nature.com/31WtiVdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read how
@PharmabcineI is advancing its lead antibody candidate through the clinic, whilst also developing a portfolio of clinical candidates that target key molecules implicated in#oncology, angiogenesis and immune surveillance in our September issuehttps://go.nature.com/2nfSXcgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read how
@abcam are tackling key challenges in the life sciences with advanced biological tools in our September issue, online now.#antibodies#oncology#lifescienceshttps://go.nature.com/2oiHJ6JHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioPharma Dealmakers proslijedio/la je Tweet
We’re featured in the SEP issue of
@bpdealmakers! As@jbuell01 said, “We are integrating advanced technologies, including AI platforms, to fuel a new wave of innovative therapies that address resistance pathways that can significantly improve treatment of patients with cancer.”https://twitter.com/bpdealmakers/status/1168533254951047168 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Immaculate therapeutic antibody discovery" Harnessing its antibody discovery platform Symplex,
@SymphogenAS has developed a fully integrated approach to discovering and developing next-generation antibody therapeutics.#antibodies#oncologyhttps://go.nature.com/2mbqd3fHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioPharma Dealmakers proslijedio/la je Tweet
"Our research communities allow scientists to tell the stories behind their research. Today over 2,500 authors have written a Behind the Paper post." James Butcher on how
@SpringerNature drive engagement and connection with their online communities.pic.twitter.com/4ZFSFlYfg0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.